Atara Biotherapeutics Q3 Earnings Preview: EPS Estimate at (0.13) USD
Atara Biotherapeutics is set to report Q3'26 results on October 29. Revenue is estimated at 800.00 thousand USD and EPS at (0.13) USD; the release time is not specified.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Atara Biotherapeutics Q3'26 Earnings Preview
Atara Biotherapeutics is scheduled to report Q3'26 results on October 29. Revenue is estimated at 800.00K USD and EPS at (0.13) USD.